Paul J. Diaz

President and CEO, Myriad Genetics, Inc.

Paul J. Diaz, was named president, chief executive officer and member of the Myriad Genetics board of directors on August 13, 2020. Paul was most recently a partner at Cressey & Company (2016-2020), a private investment firm headquartered in Chicago, Illinois, which currently manages over $3.0 billion in committed capital. Cressey & Company is a healthcare focused middle-market private equity firm with over 30 years of success investing in and helping to build high quality healthcare businesses.Read More

Maggie Ancona

Senior Vice President, Enterprise Transformation and Program Management Office, Myriad Genetics, Inc.

Maggie Ancona, senior vice president, Enterprise Transformation and Program Management Office, joined Myriad Genetics in January 2021. Previously, she led Global Transformation and Program Management at Hewlett Packard (HP) and Dell Technologies where she oversaw business transformation strategy, executed large-scale programs and cost management efforts, while retooling digital infrastructure for the future. Mrs. Ancona received a bachelor’s degree in English from the University of San Francisco.

Kevin R. Haas

Chief Technology Officer, Myriad Genetics, Inc.

Kevin R. Haas, chief technology officer, joined Myriad Genetics in May 2013. Previously, he was vice president of Bioinformatics. Dr. Haas also serves on the Board of Directors and is vice president for USA Triathlon, the non-profit national governing body for the sport. Dr. Haas received a B.S. from University of Wisconsin-Madison and a Ph.D. in Chemical Engineering from University of California-Berkeley, where he worked on molecular simulation and machine learning to study protein dynamics from single molecule fluoresce. He has co-authored 16 peer reviewed publications and eight patent applications.

Jayne B. Hart

Chief People Officer, Myriad Genetics, Inc.

Jayne B. Hart joined Myriad Genetics in May 2011 as chief people officer. She has more than twenty years of professional experience in the human resources field. Prior to joining Myriad, Ms. Hart served as vice president of human resources at LANDesk Software, a global software company. Before that, she was vice president of human resources for 360networks, a wholesale telecommunications company, and at AT&T Wireless, a global telecommunications company, where she began her career.

Nicole Lambert

President, Myriad Genetic Laboratories

Nicole Lambert, president, Myriad Genetic Laboratories, joined Myriad Genetics in June 2001. Prior to her current position, she served as general manager for the Oncology and Urology business units and vice president of Dermatology. Prior to joining Myriad, she was a genetic counselor at LabCorp. Mrs. Lambert received her bachelor’s degree in Biology and Sociology from Boston College and she earned her master’s in genetic counseling from Mt. Sinai School of Medicine at New York University.

Jerry Lanchbury

Chief Scientific Officer, Myriad Genetics, Inc.

Jerry Lanchbury, chief scientific officer, joined Myriad Genetics in September 2002. Before that, he was a researcher in molecular immunogenetics at Kings College London. He is a highly respected expert in immunogenetics with more than 100 reviewed research journal publications. Dr. Lanchbury graduated from the University of Aston, Birmingham, U.K. He earned his Ph.D. in Population Genetics from the University of Newcastle upon Tyne and subsequently completed a postdoctoral fellowship at the United Medical & Dental Schools of the University of London in Human Disease Genetics.

Bryan Riggsbee

Chief Financial Officer, Myriad Genetics, Inc.

Bryan Riggsbee, chief financial officer, joined Myriad Genetics in October 2014. He previously served 10 years with Laboratory Corporation of America (LabCorp) where his most recent position was as senior vice president of Corporate Finance with responsibility for the financial planning and analysis and treasury functions. Prior to LabCorp, Mr. Riggsbee served in various finance roles with General Electric and began his career in the audit division of KPMG. He received a B.A. degree in Accounting from North Carolina State University, a B.A. degree in Political Science from the University of North Carolina at Chapel Hill and an M.B.A. from Northwestern University. Mr. Riggsbee is a Certified Public Accountant licensed in the State of North Carolina.

Eric Santa

Chief Growth Officer, Myriad Genetics, Inc.

Eric Santa joined Myriad Genetics as enterprise chief growth officer in April 2021.  He is responsible for accelerating company growth initiatives, building new commercial and digital capabilities to better serve patients and healthcare providers while boosting market demand for Myriad products. Mr. Santa previously served as chief revenue officer of Rally Health, Inc., a division of Optum within UnitedHealth Group, where he spearheaded consumer digital health strategies and led key business functions including sales for payer, provider, and employer markets. Prior to his leadership role at Rally, he held several other strategy and leadership positions at Optum, The Boston Consulting Group and The Blue Cross and Blue Shield Association. Mr. Santa earned a Bachelor’s degree in Economics from Purdue University and a Master’s degree in Business Administration from The Kellogg School at Northwestern University.

Mark S. Verratti

President, Mental Health

Mark Verratti, president, Mental Health, joined Myriad Genetics in January 2016. He previously served as SVP and chief sales and business development officer, Mental Health. Mr. Verratti also held senior leadership positions with Forest Pharmaceuticals where he led commercial teams with revenues approaching $500 million dollars. In addition, he held senior and general management positions with Cyberonics/LivaNova leading teams in over 70 countries. He received a B.S. in Life Sciences with a minor in Physiology from The Pennsylvania State University.

Pamela Wong

Chief Legal Officer, Myriad Genetics, Inc.

Pamela Wong, chief legal officer, joined Myriad Genetics in October 2021. She leads the company’s legal function, including support and counsel for all legal affairs, intellectual property, patent protection, mergers and acquisitions, litigation, regulatory and quality assurance, compliance, and government affairs. She previously served 14 years at Quest Diagnostics, most recently as its assistant general counsel. Prior to Quest, she worked eight years at Baker-McKenzie where she was an intellectual property partner, and at Pillsbury Winthrop Shaw Pittman LLP. Ms. Wong holds a B.S. degree from the University of California-Berkeley, a Ph.D. from Florida State University-Tallahassee, and a J.D. from the University of San Diego.